Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

<p>M2 macrophage infiltration into tumor islets leads to poor prognosis in non-small-cell lung cancer</p>
Lili Cao, Xiaofang Che, Xue-shan Qiu, et al.
Cancer Management and Research (2019) Vol. Volume 11, pp. 6125-6138
Open Access | Times Cited: 111

Showing 1-25 of 111 citing articles:

Tumor-associated macrophage, angiogenesis and lymphangiogenesis markers predict prognosis of non-small cell lung cancer patients
Ilseon Hwang, Jeong Won Kim, Kris Ylaya, et al.
Journal of Translational Medicine (2020) Vol. 18, Iss. 1
Open Access | Times Cited: 192
Tumor-Associated Macrophages Regulate PD-1/PD-L1 Immunosuppression
Yunzhou Pu, Qing Ji
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 172
Targeting of CD163+ Macrophages in Inflammatory and Malignant Diseases
Maria Kløjgaard Skytthe, Jonas Heilskov Graversen, Søren K. Moestrup
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 15, pp. 5497-5497
Open Access | Times Cited: 169
Extracellular vesicles: mediators of intercellular communication in tissue injury and disease
Greg Berumen Sánchez, Kaitlyn E. Bunn, Heather H. Pua, et al.
Cell Communication and Signaling (2021) Vol. 19, Iss. 1
Open Access | Times Cited: 159
A narrative review of tumor-associated macrophages in lung cancer: regulation of macrophage polarization and therapeutic implications
Sahar Sedighzadeh, Amin Pastaki Khoshbin, Sepideh Razi, et al.
Translational Lung Cancer Research (2021) Vol. 10, Iss. 4, pp. 1889-1916
Open Access | Times Cited: 127
Immune Checkpoint Inhibitors in EGFR-Mutated NSCLC: Dusk or Dawn?
Meng Qiao, Tao Jiang, Xinyu Liu, et al.
Journal of Thoracic Oncology (2021) Vol. 16, Iss. 8, pp. 1267-1288
Closed Access | Times Cited: 115
Clearance of senescent macrophages ameliorates tumorigenesis in KRAS-driven lung cancer
Scott Haston, Estela González‐Gualda, Samir Morsli, et al.
Cancer Cell (2023) Vol. 41, Iss. 7, pp. 1242-1260.e6
Open Access | Times Cited: 105
EGFR-Mutated Non-Small Cell Lung Cancer and Resistance to Immunotherapy: Role of the Tumor Microenvironment
Clelia Madeddu, Clelia Donisi, Nicole Liscia, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 12, pp. 6489-6489
Open Access | Times Cited: 82
Targeting the PD-1/PD-L1 Signaling Pathway for Cancer Therapy: Focus on Biomarkers
Αreti Strati, Christos Adamopoulos, Ioannis Kotsantis, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 3, pp. 1235-1235
Open Access | Times Cited: 2
Macrophage and Tumor Cell Cross-Talk Is Fundamental for Lung Tumor Progression: We Need to Talk
Poonam Sarode, Martina Barbara Schaefer, Friedrich Grimminger, et al.
Frontiers in Oncology (2020) Vol. 10
Open Access | Times Cited: 105
CD68- and CD163-positive tumor-associated macrophages in triple negative cancer of the breast
Tsengelmaa Jamiyan, Hajime Kuroda, Rin Yamaguchi, et al.
Virchows Archiv (2020) Vol. 477, Iss. 6, pp. 767-775
Open Access | Times Cited: 70
Immune-based therapies in penile cancer
Vidhu B. Joshi, Philippe E. Spiess, Andrea Necchi, et al.
Nature Reviews Urology (2022) Vol. 19, Iss. 8, pp. 457-474
Open Access | Times Cited: 42
Prognostic value of CD163+ macrophages in solid tumor malignancies: A scoping review
Henriette Mathiesen, Kristian Juul‐Madsen, Trine Tramm, et al.
Immunology Letters (2025), pp. 106970-106970
Open Access | Times Cited: 1
Tumor‑associated macrophages in lung cancer: Friendly or evil? (Review)
Fei Xu, Ying Wei, Zhao Tang, et al.
Molecular Medicine Reports (2020)
Open Access | Times Cited: 61
The Significance of Secreted Phosphoprotein 1 in Multiple Human Cancers
Tengteng Wei, Guoshu Bi, Yunyi Bian, et al.
Frontiers in Molecular Biosciences (2020) Vol. 7
Open Access | Times Cited: 56
CXCL12 derived from CD248-expressing cancer-associated fibroblasts mediates M2-polarized macrophages to promote nonsmall cell lung cancer progression
Jieheng Wu, Xinlei Liu, Jiangwei Wu, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2022) Vol. 1868, Iss. 11, pp. 166521-166521
Open Access | Times Cited: 33
Tumor-associated macrophages affect the treatment of lung cancer
Zhuchen Yu, Juntao Zou, Fei Xu
Heliyon (2024) Vol. 10, Iss. 7, pp. e29332-e29332
Open Access | Times Cited: 6
PD-1/PD-L1 expression profiles within intrahepatic cholangiocarcinoma predict clinical outcome
Lingyu Tian, Jiaqiang Ma, Lijie Ma, et al.
World Journal of Surgical Oncology (2020) Vol. 18, Iss. 1
Open Access | Times Cited: 41
Tumor Cells Modulate Macrophage Phenotype in a Novel In Vitro Co-Culture Model of the NSCLC Tumor Microenvironment
Josiah Voth Park, Raghav Chandra, Ling Cai, et al.
Journal of Thoracic Oncology (2022) Vol. 17, Iss. 10, pp. 1178-1191
Open Access | Times Cited: 27
Exosomal AP000439.2 from clear cell renal cell carcinoma induces M2 macrophage polarization to promote tumor progression through activation of STAT3
Tianyi Shen, Suqin Miao, Yulin Zhou, et al.
Cell Communication and Signaling (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 26
The role of macrophages in non-small cell lung cancer and advancements in 3D co-cultures
Katarína Balážová, Hans Clevers, Antonella F. M. Dost
eLife (2023) Vol. 12
Open Access | Times Cited: 14
Prognostic value of immune cells in the tumor microenvironment of early-stage lung cancer: a meta-analysis
Stephanie Tuminello, Rajwanth Veluswamy, Wil Lieberman‐Cribbin, et al.
Oncotarget (2019) Vol. 10, Iss. 67, pp. 7142-7155
Open Access | Times Cited: 41
Lung Microbiome Differentially Impacts Survival of Patients with Non-Small Cell Lung Cancer Depending on Tumor Stroma Phenotype
О. В. Ковалева, P. A. Podlesnaya, M. A. Rashidova, et al.
Biomedicines (2020) Vol. 8, Iss. 9, pp. 349-349
Open Access | Times Cited: 39
Functional and mechanistic advantage of the use of a bifunctional anti-PD-L1/IL-15 superagonist
Karin M. Knudson, Kristin C. Hicks, Yohei Ozawa, et al.
Journal for ImmunoTherapy of Cancer (2020) Vol. 8, Iss. 1, pp. e000493-e000493
Open Access | Times Cited: 37
Next-Generation Digital Histopathology of the Tumor Microenvironment
Felicitas Mungenast, Achala Fernando, Robert Nica, et al.
Genes (2021) Vol. 12, Iss. 4, pp. 538-538
Open Access | Times Cited: 31
Page 1 - Next Page

Scroll to top